While chemotherapy increases survival rates by reducing rates of recurrence in these high risk subgroups [ 1 ], there may be significant side effects including loss of hair, taste, cognitive function, and additional extensive medical care [ 2 ].
← all excerpts
Quantitative nuclear histomorphometry predicts oncotype DX risk categories for early stage ER+ breast cancer.
1
—
—